Kimberly Clark Corp Shares Downgraded by Janney Montgomery Scott to “Neutral” (KMB)

Kimberly Clark Corp (NYSE: KMB) was downgraded by investment analysts at Janney Montgomery Scott from a “buy” rating to a “neutral” rating in a note issued to investors on Wednesday.

Separately, analysts at Zacks Investment Research reiterated a “neutral” rating on shares of Kimberly Clark Corp in a research note to investors on Thursday, February 9th. They now have a $75.00 price target on the stock. Analysts at UBS AG (NYSE: UBS) downgraded shares of Kimberly Clark Corp from a “buy” rating to a “neutral” rating in a research note to investors on Wednesday, January 25th. They now have a $75.00 price target on the stock, down previously from $77.00. Also, analysts at CLSA downgraded shares of Kimberly Clark Corp from an “outperform” rating to an “underperform” rating in a research note to investors on Wednesday, January 25th.

Kimberly-Clark Corporation is a global health and hygiene company focused on product innovation and building its personal care, consumer tissue, K-C Professional and Other and health care brands. The Company is principally engaged in the manufacturing and marketing of a range of health and hygiene products worldwide. The Company operates in four segments: Personal Care; Consumer Tissue; K-C Professional & Other, and Health Care. The Personal Care segment manufactures and markets disposable diapers, training and youth pants, and swimpants; baby wipes; feminine and incontinence care products, and related products. The Consumer Tissue segment manufactures and markets facial and bathroom tissue and paper towels. The K-C Professional & Other segment manufactures and markets facial and bathroom tissue, paper towels, napkins, wipers and a range of safety products. The Health Care segment manufactures and markets disposable health care products.

Kimberly Clark Corp traded down 0.31% on Wednesday, hitting $71.405. Kimberly Clark Corp has a 52-week low of $61.00 and a 52-week high of $74.25. The stock has a 50-day moving average of $72.59 and a 200-day moving average of $70.10. The company has a market cap of $28.255 billion and a price-to-earnings ratio of 17.95.